Date:2/13/2009

-------------- Three months ended Six months ended December 31, December 31, 2008 2007 2008 2007 ------------------------------------------------------------------------- (Unaudited) (Unaudited) Out-licensing revenue $ 1,832,224 $ 1,155,833 $ 3,047,169 $ 2,282,766 Interest income 365,067 727,242 807,688 1,417,634 ------------------------------------------------------------------------- 2,197,291 1,883,075 3,854,857 3,700,400 Expenses: General and admini- strative 1,193,209 2,075,506 2,340,587 4,109,516 Licensing and product development 4,421,428 4,220,627 8,266,612 7,765,486 ----------------------------------------------------------------------- 5,614,637 6,296,133 10,607,199 11,875,002 ------------------------------------------------------------------------- Loss before the undernoted (3,417,346) (4,413,058) (6,752,342) (8,174,602) Gain (loss) on foreign exchange 79,684 (29,773) 91,887 14,132 Realized gain on short-term deposits - 110,337 - 133,290 Unrealized gain (loss) on short-term deposits 163,277 (77,251) 22,718 (6,874) Loss on disposal of property and equipment - (70,143) - (70,143) Other income - - 307,140 - ------------------------------------------------------------------------- Loss and comprehensive
'/>"/>

SOURCE YM BioSciences Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10
Related biology technology :

1. Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results
2. Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
3. Sangamo BioSciences Announces Fourth Quarter and Year-End 2008 Conference Call and Webcast
4. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2008 Financial Results
5. BD Biosciences to Distribute FCS Express
6. MichBio Will Publish 2009 Michigan Biosciences Directory and Resource Guide
7. Cell Biosciences Introduces Kits for Oncoprotein Analysis
8. Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
9. Cyntellect Appoints Former Millipore and BD Biosciences Executives to Head Up its Product Marketing Efforts
10. Sigma-Aldrich and Sangamo BioSciences Announce the Achievement of Key Throughput Milestone in Research Reagents Agreement
11. Alliance Biosciences Announces Trade Mission to Singapore with Speaker Presentation at International Lab Design Seminar